All SightGlass Vision articles
-
News briefs
SightGlass Vision reinforces medical and professional affairs team
SightGlass Vision, the EssilorLuxottica and CooperVision joint venture developing myopia management lenses, is reinforcing its medical and professional affairs team with two appointments. David Webley has been appointed Senior Director, Clinical, Medical and Professional Affairs. He has previously held similar roles at Vision Express in the UK and ...
-
News briefs
SightGlass Vision presents two new DOT lenses studies
SightGlass Vision, the joint venture between CooperVision and EssilorLuxottica, presented the results of two new clinical studies on its DOT myopia management lenses at the 2025 Netherlands Contact Lens Congress on March 9, 2025. Based on two different 12-month clinical trials – one in North America with Caucasian ...
-
News briefs
EssilorLuxottica gets myopia management head start in the US with Stellest’s FDA approval
Following the recognition of Stellest as a Breakthrough Device by the Food and Drugs Administration (FDA) in 2021, EssilorLuxottica announced yesterday that the US health regulator has now granted market authorization for its myopia management lens. Stellest, which clinical data showed is slowing down myopia progression by 71 percent on ...
-
News briefs
SightGlass Vision launches DOT lenses in the UK
SightGlass Vision, the joint venture between CooperVision and EssilorLuxottica, has announced the launch in the UK of its DOT myopia control lenses. The company says that it will be hosting an introductory webinar on Oct. 15 for eye care professionals in the country. DOT lenses are already distributed in China, ...
-
News briefs
SightGlass Vision DOT lenses used by 1 million children
SightGlass Vision, the EssilorLuxottica and CooperVision joint venture, has announced that its Diffusion Optics Technology (DOT) myopia management lenses have been worn by one million children globally since the launch in 2021. The lenses are currently available in China, the Netherlands, Israel, Canada and Spain, with ongoing market trials in ...
-
News briefs
SightGlass Vision announces new clinical research results
SightGlass Vision, a joint venture between EssilorLuxottica and CooperVision, is presenting new clinical research related to its Diffusion Optics Technology (DOT) at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) currently taking place in Salt Lake City, Utah. SightGlass Vision says that a recent study ...
-
News briefs
SightGlass Vision releases first white paper on DOT
SightGlass Vision, the myopia management glasses joint venture between EssilorLuxottica and CooperVision, has released on its website its first white paper on its Diffusion Optics Technnology. Aimed at eye care professionals, the document provides information on the relationship between artificially high contrast signals at the retina and myopia progression, on ...
-
ArticleCVI up 11% organically, sees myopia management segment breaking even
CooperCompanies has reported a 2 percent year-on-year increase to $566.3 million in sales for its CooperVision unit in Q3, slowed down by strong currency headwinds. The division’s revenue grew by 10 percent at constant exchange rates and by 11 percent on an organic basis compared to the same quarter last ...
-
News briefs
Encouraging results for Sightglass Vision’s myopia glasses
Interim data from the first 24 months of a CYPRESS clinical trial suggest that glasses with SightGlass Vision’s Diffusion Optics Technology reduce both axial length and cycloplegic SER progression in six- and seven-year-old children. A paper on the trial – titled “Two Year Effectiveness of a Novel Myopia Management Spectacle ...
-
ArticleMyopia management research updates presented at ARVO
Three recent studies by the three main players that have developed myopia management eyeglass lenses were presented at the Association for Research in Vision and Ophthalmology (ARVO) conference earlier this month. Hoya Vision Care has announced results from a six-year study of its MiYoSmart lens, which is based on the ...
-
News briefs
Executive changes at Cooper and Essilux JV SightGlass
In connection with the freshly established joint venture between CooperCompanies and EssilorLuxottica, SightGlass Vision has made three executive appointments. First off, Andrew Sedgwick, until now CooperVision’s senior vice president of commercial strategy, is now CEO of SightGlass. He had been with CooperVision for about two decades, serving also as president ...
-
News briefs
Essilux and CooperVision finalize SightGlass Vision JV
A year after the initial announcement of their partnership, EssilorLuxottica and CooperVision have confirmed the finalization of their joint venture agreement for the development of SightGlass Vision, a new lens in the myopia management segment. During its last results’ presentation, CooperVision said that the two partners were still discussing the ...
-
ArticleEMEA and APAC drove CooperVision Q1 growth
CooperCompanies has reported a 16 percent year-on-year revenue increase to $787.2 million for the first quarter of its 2022 financial year, with double-digit progress for both its CooperVision and CooperSurgical divisions. CooperVision Q1 sales rose by 11 percent in reported terms as compared to the same period in 2020, or ...
-
ArticleFirst launch and 2-year trial results announced for SightGlass Vision
In conjunction with the commercial launch of the product in the Netherlands, CooperVision released last week the results of the ongoing clinical trial on the performance of its SightGlass Vision lenses in terms of myopia progression reduction after two years of research. The CYPRESS clinical study, as it is called, ...
-
ArticleEssilux ramps up Stellest
Only a few days after announcing significant developments for its myopia management lens in China and the U.S. during its conference call with financial investors, EssilorLuxottica disclosed updated results on its Stellest research during the online congress of the Société Française d’Ophtalmologie a few days ago and confirmed a launch ...
-
ArticleEssilorLuxottica revenues top 2019 level
EssilorLuxottica confirms its growth trajectory started in the second half of 2020, with sales for the first quarter surging by 7.3 percent from the year-ago quarter to €4,060 million, or by 14.3 percent in constant currencies. This is even 1.9 percent above the level of the first ...
-
ArticleEssilux to buy 50% of SightGlass Vision from CooperCompanies
EssilorLuxottica will buy a 50 percent stake of SightGlass Vision, which focuses on developing lenses to reduce the progression of myopia in children, from CooperCompanies, the parent company of CooperVision. CooperCompanies held a minority ownership interest in SightGlass Vision and bought the company in January. Under the agreement with Essilux, ...
